![](/img/cover-not-exists.png)
Impaired fasting glucose level as metabolic side effect of nilotinib in non-diabetic chronic myeloid leukemia patients resistant to imatinib
M. Breccia, M. Muscaritoli, F. Gentilini, R. Latagliata, I. Carmosino, F. Rossi Fanelli, G. AlimenaVolume:
31
Year:
2007
Language:
english
Pages:
3
DOI:
10.1016/j.leukres.2007.01.024
File:
PDF, 239 KB
english, 2007